RU2007116944A - Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости - Google Patents
Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости Download PDFInfo
- Publication number
- RU2007116944A RU2007116944A RU2007116944/15A RU2007116944A RU2007116944A RU 2007116944 A RU2007116944 A RU 2007116944A RU 2007116944/15 A RU2007116944/15 A RU 2007116944/15A RU 2007116944 A RU2007116944 A RU 2007116944A RU 2007116944 A RU2007116944 A RU 2007116944A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- salivary
- drying
- lacrimal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (7)
1. Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости, которая содержит в качестве активного ингредиента (-)-(S)-2,8-диметил-3-метилен-1-оксо-8-азаспиро[4,5] декан или его фармацевтически приемлемую соль.
2. Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости по п.1, в которой активный ингредиент представляет собой моногидрат L-тартрата соединения, определенного в п.1.
3. Фармацевтическая композиция по п.1, имеющая селективное действие на повышение секреции слезной и слюнной жидкости.
4. Фармацевтическая композиция по п.1 или 3, обладающая эффектом стимуляции роста железистых клеток.
5. Фармацевтическая композиция по п.1 или 3, имеющая форму препарата с замедленным высвобождением.
6. Фармацевтическая композиция по п.5, которая содержит соединение, определенное в п.1, или его фармацевтически приемлемую соль, и фармацевтический носитель замедленного высвобождения.
7. Фармацевтическая композиция по п.2, используемая при таких болезнях, как ревматизм, аутоимунные болезни, внутренние болезни, старческая атрофия слюнных желез и слезных желез, аллергический кератит и конъюнктивит, вирусные болезни, нарушения слюнных желез и слезных желез вследствие ионизирующего облучения, старения, психологической усталости и сухости, вызываемой побочным эффектом при введении лекарственного средства.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-292611 | 2004-10-05 | ||
| JP2004292611 | 2004-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007116944A true RU2007116944A (ru) | 2008-11-20 |
Family
ID=36142669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007116944/15A RU2007116944A (ru) | 2004-10-05 | 2005-10-04 | Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20070105934A1 (ru) |
| EP (1) | EP1712230A1 (ru) |
| JP (1) | JPWO2006038596A1 (ru) |
| KR (1) | KR20070061578A (ru) |
| CN (1) | CN101031297A (ru) |
| AU (1) | AU2005290532A1 (ru) |
| BR (1) | BRPI0516468A (ru) |
| CA (1) | CA2582615A1 (ru) |
| IL (1) | IL182124A0 (ru) |
| MX (1) | MX2007003994A (ru) |
| NO (1) | NO20072328L (ru) |
| RU (1) | RU2007116944A (ru) |
| TW (1) | TW200616628A (ru) |
| WO (1) | WO2006038596A1 (ru) |
| ZA (1) | ZA200702784B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090082381A1 (en) * | 2005-07-26 | 2009-03-26 | Akiharu Isowaki | Percutaneously Absorbable Ophthalmic Preparation |
| US10338203B2 (en) | 2011-09-09 | 2019-07-02 | Siemens Medical Solutions Usa, Inc. | Classification preprocessing in medical ultrasound shear wave imaging |
| JP6526475B2 (ja) * | 2015-04-30 | 2019-06-05 | サンスター株式会社 | 経皮唾液腺投与用の唾液分泌促進剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2683783B2 (ja) * | 1992-07-10 | 1997-12-03 | 雪印乳業株式会社 | シェーグレン症候群治療剤 |
| ATE219933T1 (de) * | 1992-09-18 | 2002-07-15 | Yamanouchi Pharma Co Ltd | Hydrogelzubereitung mit verzögerter freisetzung |
| JPH07126163A (ja) * | 1993-10-08 | 1995-05-16 | Theratech Inc | 制御放出性ピロカルピン送達システム |
| US6528529B1 (en) * | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| US20020142033A1 (en) * | 1998-05-05 | 2002-10-03 | Gupta Suneel K. | Method for treating incontinence |
| US20020028240A1 (en) * | 2000-04-17 | 2002-03-07 | Toyohiro Sawada | Timed-release compression-coated solid composition for oral administration |
| JP2003063964A (ja) * | 2001-08-28 | 2003-03-05 | Senju Pharmaceut Co Ltd | ドライアイまたはドライアイを伴なう疾病の予防治療剤 |
-
2005
- 2005-10-04 RU RU2007116944/15A patent/RU2007116944A/ru not_active Application Discontinuation
- 2005-10-04 TW TW094134706A patent/TW200616628A/zh unknown
- 2005-10-04 CA CA002582615A patent/CA2582615A1/en not_active Abandoned
- 2005-10-04 US US10/578,682 patent/US20070105934A1/en not_active Abandoned
- 2005-10-04 ZA ZA200702784A patent/ZA200702784B/xx unknown
- 2005-10-04 MX MX2007003994A patent/MX2007003994A/es not_active Application Discontinuation
- 2005-10-04 BR BRPI0516468-0A patent/BRPI0516468A/pt not_active IP Right Cessation
- 2005-10-04 WO PCT/JP2005/018310 patent/WO2006038596A1/ja active Application Filing
- 2005-10-04 AU AU2005290532A patent/AU2005290532A1/en not_active Abandoned
- 2005-10-04 EP EP05790491A patent/EP1712230A1/en not_active Withdrawn
- 2005-10-04 KR KR1020077010162A patent/KR20070061578A/ko not_active Application Discontinuation
- 2005-10-04 CN CNA2005800329427A patent/CN101031297A/zh active Pending
- 2005-10-04 JP JP2006539287A patent/JPWO2006038596A1/ja not_active Withdrawn
-
2007
- 2007-03-22 IL IL182124A patent/IL182124A0/en unknown
- 2007-05-04 NO NO20072328A patent/NO20072328L/no not_active Application Discontinuation
- 2007-09-26 US US11/861,725 patent/US20080131511A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200616628A (en) | 2006-06-01 |
| CN101031297A (zh) | 2007-09-05 |
| US20070105934A1 (en) | 2007-05-10 |
| US20080131511A1 (en) | 2008-06-05 |
| EP1712230A1 (en) | 2006-10-18 |
| AU2005290532A1 (en) | 2006-04-13 |
| NO20072328L (no) | 2007-06-29 |
| MX2007003994A (es) | 2007-06-15 |
| KR20070061578A (ko) | 2007-06-13 |
| CA2582615A1 (en) | 2006-04-13 |
| ZA200702784B (en) | 2008-09-25 |
| WO2006038596A1 (ja) | 2006-04-13 |
| BRPI0516468A (pt) | 2008-09-09 |
| IL182124A0 (en) | 2007-07-24 |
| JPWO2006038596A1 (ja) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2233273C3 (ru) | Ароматические азотсодержащие 6-членные циклические соединения и фармацевтическая композиция | |
| EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
| RU2005138915A (ru) | Сульфонамид замещенные имидазохинолины | |
| PE20060383A1 (es) | Nuevos derivados amino de urea ciclicos como inhibidores de quinasa | |
| BRPI0411825B8 (pt) | inibidores de p38 quinase a base de heterociclo de 5 elementos, seus processos de preparação e seus usos, bem como composição farmacêutica | |
| HRP20171917T1 (hr) | Terapeutski pripravci koji sadrže macitentan | |
| BRPI0517425A (pt) | composto ou um sal, solvato, enanciÈmero, diastereÈmero ou mistura de diastereÈmeros do mesmo, composição farmacêutica, uso de composto | |
| HRP20220642T1 (hr) | Postupci za liječenje depresije uporabom antagonista receptora oreksina 2 | |
| ATE446962T1 (de) | Thiazolopyridinon-derivate als mch- rezeptorantagonisten | |
| PE20080947A1 (es) | Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas como antagonistas de receptores de tipo trpv1 | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| EA200702523A1 (ru) | Применение эритропоэтина в низкой дозировке для стимуляции эндотелиальных клеток-предшественников, а также для регенерации органов и замедления прогрессирования повреждений конечных органов | |
| RU2010148787A (ru) | Чрескожно абсорбируемый препарат | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| RU2007116944A (ru) | Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости | |
| PE20061055A1 (es) | DERIVADOS DE OCTAHIDROPIRROLO[3,4-c]PIRROL COMO LIGANDOS DEL RECEPTOR DE HISTAMINA H4 | |
| RU2009129212A (ru) | Неиммуносупрессорный циклоспорин для лечения врожденной миопатии ульриха | |
| ATE444069T1 (de) | Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen | |
| BR0111267A (pt) | Cicloexilaminas bicìclicas e seu uso como antagonistas do receptor de nmda | |
| KR20090050091A (ko) | 녹내장 또는 그의 진행을 치료 또는 예방하기 위한 조성물 및 방법 | |
| EA200701601A1 (ru) | Антигельминтные производные имидазола и тиазола | |
| RU2005135649A (ru) | Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги | |
| DE60327634D1 (de) | Mittel zur behandlung des integrationsdysfunktionssyndroms | |
| Parsaee et al. | Effects of hydro-ethanolic extract of berberis vulgaris fruit on rabbit isolated heart | |
| RU2002115270A (ru) | Соединения и способ для лечения боли |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20091118 |